| Literature DB >> 35114708 |
Carola de la Guardia1, Ada Virno2, Maria Musumeci1, Aude Bernardin3, Michael B Silberberg1.
Abstract
Injections with hyaluronic acid (HA) fillers for facial rejuvenation and soft-tissue augmentation are among the most popular aesthetic procedures worldwide. Many HA fillers are available with unique manufacturing processes and distinct in vitro physicochemical and rheologic properties, which result in important differences in the fillers' clinical performance. The aim of this paper is to provide an overview of the properties most widely used to characterize HA fillers and to report their rheologic and physicochemical values obtained using standardized methodology to allow scientifically based comparisons. Understanding rheologic and physicochemical properties will guide clinicians in aligning HA characteristics to the facial area being treated for optimal clinical performance. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Mesh:
Substances:
Year: 2022 PMID: 35114708 PMCID: PMC9188840 DOI: 10.1055/s-0041-1741560
Source DB: PubMed Journal: Facial Plast Surg ISSN: 0736-6825 Impact factor: 1.286
Fig. 1Schematic representation of a rheometer in oscillation mode. The gel is placed between two plates of defined geometry to assess elasticity (solid behavior) quantified by the elastic modulus, or G′, indicating how much the gel can recover its shape after shear stress. The same experiment also measures G″, the viscous modulus. From these measured parameters, G* and tan delta (δ) can be calculated. 11 17 20
Rheologic and physicochemical characteristics of HA fillers measured in vitro
| Parameters | Definitions | Relevance |
|---|---|---|
|
Complex modulus
| G*, or hardness, measures overall viscoelastic properties of a gel. |
For most HA fillers, G* and G' are similar. The value of G* is derived from the formula
|
|
Elastic modulus
| G′, or elasticity, measures the elastic properties of the gel and its ability to recover its shape after shearing stress is removed. | The most common descriptor for HA fillers, G′ is a measure of the strength (firmness). G′ is influenced by the degree of crosslinking and total HA concentration. |
|
Viscous modulus
| G″, or loss modulus, measures the viscous properties of the gel and its inability to recover its shape. | HA fillers tend to have low G″. |
|
Tan delta (δ)
| Tan δ is the ratio between the viscous and the elastic components of the HA gel (G″/G′). | Tan δ characterizes whether the gel is more viscous or more elastic (proportion of G″ to G′). Tan δ is usually low in crosslinked HA fillers, meaning that the elastic behavior under low shear stress is dominant over the viscous behavior. |
|
Gel cohesion (cohesivity)
| Cohesivity measures the resistance to vertical compression/stretching. | This property characterizes how a filler behaves as a gel deposit once it is injected and subjected to forces. Gel cohesion is influenced by HA concentration and the crosslinking and sizing/homogenization of the gel. |
|
Water uptake
| Water uptake, or swelling factor, measures the ability of the gel to swell from water uptake. | Water uptake/swelling factor helps anticipate the initial volumization of an implanted gel. |
|
HA concentration
| This parameter is the total amount of HA found in the filler, expressed as mg/mL, and includes insoluble and soluble HA. | Insoluble HA is the crosslinked HA and the foundation for the effectiveness and durability of the filler. Soluble HA is the noncross-linked and rapidly degradable form of HA (from HA fragments, or usually added for facilitating extrusion). HA concentration impacts all the parameters. |
Abbreviation: HA, hyaluronic acid.
Rheologic and physicochemical characteristics of HA fillers (data from Hee et al 13 and data on file, Allergan Aesthetics, an AbbVie company). All products were tested under the same conditions using the same methodologies 13
|
Filler product name
| HA (mg/mL) | G' 5Hz (Pa) | G'' 5Hz (Pa) | Tan δ | Cohesivity/Fn (gmf) | Maximum water uptake, % |
|---|---|---|---|---|---|---|
| Belotero Soft+ | 20 | 40 | 42 | 1.050 | 16 | <100 |
| Belotero Balance+ / Lips Contour | 22.5 | 128 | 82 | 0.641 | 69 | 664 |
| Belotero Intense+ / Lips Shape | 25.5 | 255 | 110 | 0.431 | 115 | 700 |
| Belotero Volume+ | 26 | 438 | 103 | 0.235 | 97 | 370 |
| Juvéderm Ultra | 24 | 156 | 68 | 0.436 | 96 | 580 |
| Juvéderm Ultra XC | 24 | 207 | 80 | 0.386 | 96 | 622 |
| Juvéderm Ultra Plus | 24 | 214 | 74 | 0.346 | 116 | 515 |
| Juvéderm Ultra Plus XC | 24 | 263 | 79 | 0.300 | 112 | 454 |
| Juvéderm Ultra 2 | 24 | 188 | 75 | 0.399 | 95 | 574 |
| Juvéderm Ultra 3/Smile | 24 | 238 | 71 | 0.298 | 104 | 426 |
| Juvéderm Ultra 4 | 24 | 164 | 66 | 0.402 | 105 | 614 |
| Juvéderm Volite | 12 | 166 | 30 | 0.181 | 12 | <100 |
| Juvéderm Volbella with lidocaine | 15 | 271 | 39 | 0.144 | 19 | 133 |
| Juvéderm Volift with lidocaine | 17.5 | 340 | 46 | 0.135 | 30 | 184 |
| Juvéderm Voluma with lidocaine | 20 | 398 | 41 | 0.103 | 40 | 227 |
| Juvéderm Volux | 25 | 665 | 49 | 0.074 | 93 | 253 |
| Restylane Fynesse | 20 | 134 | 58 | 0.433 | 30 | 677 |
| Restylane Refyne | 20 | 116 | 50 | 0.431 | 49 | 516 |
| Restylane Kysse | 20 | 236 | 50 | 0.212 | 85 | 373 |
| Restylane Defyne | 20 | 342 | 47 | 0.137 | 60 | 318 |
| Restylane Volyme | 20 | 239 | 50 | 0.209 | 91 | 354 |
| Restylane Vital Light | 12 | 84 | 49 | 0.583 | 12 | <100 |
| Restylane Vital | 20 | 667 | 172 | 0.258 | 27 | <100 |
| Restylane | 20 | 864 | 185 | 0.214 | 29 | <100 |
| Restylane Lyps | 20 | 976 | 166 | 0.170 | 31 | <100 |
| Restylane Lyft | 20 | 977 | 198 | 0.203 | 32 | <100 |
| Restylane SubQ | 20 | 1055 | 123 | 0.117 | 42 | <100 |
| Teosyal Puresense Redensity II | 15 | 114 | 43 | 0.372 | 16 | 239 |
| Teosyal Puresense First Lines | 20 | 105 | 44 | 0.419 | 18 | 250 |
| Teosyal Puresense Kiss | 25 | 314 | 66 | 0.209 | 74 | 380 |
| Teosyal Puresense Deep Lines | 25 | 301 | 64 | 0.214 | 82 | 300 |
| Teosyal Puresense Ultra Deep | 25 | 348 | 54 | 0.155 | 87 | 250 |
| Teosyal RHA1 | 15 | 133 | 54 | 0.406 | 22 | 260 |
| Teosyal RHA2 | 23 | 319 | 99 | 0.310 | 77 | 420 |
| Teosyal RHA3 | 23 | 264 | 67 | 0.254 | 109 | 427 |
| Teosyal RHA4 | 23 | 346 | 62 | 0.179 | 115 | 366 |
Abbreviation: HA, hyaluronic acid.
All product trade names are the property of the respective owners (Belotero products, Merz Aesthetics; Juvéderm products, Allergan Aesthetics, an AbbVie company; Restylane products, Galderma Laboratories, LP; Teosyal products, Teoxane Laboratories). All products tested, except Juvéderm Ultra and Juvéderm Ultra Plus, contained lidocaine.
Fig. 2HA filler characteristics recommended in facial aesthetics. HA, hyaluronic acid.